Affiliation: Joint United Nations Programme on HIV/AIDS
- Gender, sex, and HIV: how well are we addressing the imbalance?Catherine Hankins
Evidence, Monitoring, and Policy, Joint United Nations Programme on HIV AIDS, 1211 Geneva 27, Switzerland
Curr Opin HIV AIDS 3:514-20. 2008..Heightened interest in sex and gender differences in HIV warrant a review of the status of current understanding of their determinants and progress in addressing them...
- Planning for pre-exposure prophylaxis to prevent HIV transmission: challenges and opportunitiesSusan C Kim
O Neill Institute for National and Global Health Law, Georgetown University, Washington, DC, USA
J Int AIDS Soc 13:24. 2010..This paper identifies the key action points that emerged from the Planning for PrEP meeting...
- Asking the right questions: developing evidence-based strategies for treating HIV in women and childrenQuarraisha Abdool Karim
Department of Epidemiology, Columbia University, New York, USA
BMC Public Health 11:388. 2011..The guideline's new goals present an opportunity for advancing the women and children's agenda outlined in the Consensus Statement...
- Combination prevention: a deeper understanding of effective HIV preventionCatherine A Hankins
Office of the Deputy Executive Director, Programme Branch, Joint United Nations Programme on HIV AIDS, Geneva, Switzerland
AIDS 24:S70-80. 2010....
- From a vicious circle to a virtuous circle: reinforcing strategies of risk, vulnerability, and impact reduction for HIV preventionCatherine Hankins
Social Mobilisation and Strategic Information Department, UNAIDS-Joint United Nations Programme on HIV/AIDS, CH-1211 Geneva 27, Switzerland
Lancet 364:1915-6. 2004
- Voluntary medical male circumcision: an introduction to the cost, impact, and challenges of accelerated scaling upCatherine Hankins
Joint United Nations Programme on HIV AIDS, Geneva, Switzerland
PLoS Med 8:e1001127. 2011..This collection of articles on determining the cost and impact of VMMC for HIV prevention signposts the way forward to scaling up VMMC service delivery safely and efficiently to reap individual- and population-level benefits...
- Towards universal access to HIV prevention, treatment, care, and support: the role of tuberculosis/HIV collaborationAlasdair Reid
Stop TB Department, WHO, Geneva, Switzerland
Lancet Infect Dis 6:483-95. 2006....
- Male circumcision: implications for women as sexual partners and parentsCatherine Hankins
Department of Policy, Evidence and Partnerships and Chief Scientific Adviser to UNAIDS, Geneva, Switzerland
Reprod Health Matters 15:62-7. 2007
- Gender-sensitive reporting in medical researchShirin Heidari
International AIDS Society, Geneva, Switzerland
J Int AIDS Soc 15:11. 2012..Journal editors are also promoters of ethical research and adequate standards of reporting, and requirements for inclusion of gender analyses should be integrated into editorial policies as a matter of urgency...
- The potential impact of male circumcision on HIV in Sub-Saharan AfricaBrian G Williams
World Health Organization, Stop TB Department, Geneva, Switzerland
PLoS Med 3:e262. 2006..We explore the implications of this finding for the promotion of MC as a public health intervention to control HIV in sub-Saharan Africa...
- Expanding research capacity and accelerating AIDS vaccine development in AsiaJean Louis Excler
International AIDS Vaccine Initiative IAVI, Geneva, Switzerland
Southeast Asian J Trop Med Public Health 39:766-84. 2008....
- Transmission of HIV-1 infection in sub-Saharan Africa and effect of elimination of unsafe injectionsGeorge P Schmid
WHO, Geneva, Switzerland
Lancet 363:482-8. 2004..Increased efforts are needed to reduce sexual transmission of HIV-1...
- [Male circumcision--an evidence-based preventive measure]Nicolai Lohse
Ugeskr Laeger 170:2359; author reply 2360. 2008
- Influence of human papillomavirus type 16 (HPV-16) E2 polymorphism on quantification of HPV-16 episomal and integrated DNA in cervicovaginal lavages from women with cervical intraepithelial neoplasiaNaoufel Azizi
Laboratoire de Virologie Moleculaire, Centre de recherche du Centre Hospitalier de l Universite de Montreal, Montreal, Quebec, Canada
J Gen Virol 89:1716-28. 2008..24) or CIN-1 (5 of 14, P=0.50). HPV-16 E2 polymorphism was a significant factor that influenced measures of HPV-16 integrated viral load...
- Sex, drugs, and gender? High time for lived experience to inform actionCatherine Hankins
Int J Drug Policy 19:95-6. 2008
- Gender and the use of antiretroviral treatment in resource-constrained settings: findings from a multicenter collaborationPaula Braitstein
Department of Medicine, Indiana University, Indianapolis, Indiana, USA
J Womens Health (Larchmt) 17:47-55. 2008....
- Polymorphism of the L1 capsid gene and persistence of human papillomavirus type 52 infection in women at high risk or infected by HIVSimon Gagnon
Laboratoire de Virologie Moleculaire, Centre de Recherche and Département de Microbiologie Infectiologie, Centre Hospitalier de l Universite de Montreal, Montreal, Quebec, Canada
J Acquir Immune Defic Syndr 44:61-5. 2007..45). L1 variations are unlikely to predispose to HPV-52 persistence and thus do not help to identify women at greater risk for HSILs...
- AIDS in AfricaPeter D Ghys
Lancet 360:1425; author reply 1425. 2002
- Back to basics in HIV prevention: focus on exposureElizabeth Pisani
Family Health International, Bangkok, Thailand
BMJ 326:1384-7. 2003
- Human papillomavirus and HIV coinfection and the risk of neoplasias of the lower genital tract: a review of recent developmentsAlex Ferenczy
Department of Pathology, McGill University and Sir Mortimer B Davis Jewish General Hospital, Montreal, QC
CMAJ 169:431-4. 2003..In addition, we present strategies for monitoring and treating noninvasive and invasive neoplasias of the lower genital tract in HIV-positive women...
- Molecular analysis of human papillomavirus type 52 isolates detected in the genital tract of human immunodeficiency virus-seropositive and -seronegative womenJoséphine Aho
Laboratoire de Virologie Moleculaire, Centre de Recherche du Centre Hospitalier, and Département de Microbiologie et Immunologie, Université de Montréal Montréal, Canada
J Infect Dis 188:1517-27. 2003..White women were more frequently infected by the prototype strain than were women of African descent (P=.0001). The genetic diversity of HPV-52 should facilitate the investigation of the role of genomic variations in cervical disease...
- Achieving the WHO/UNAIDS antiretroviral treatment 3 by 5 goal: what will it cost?Juan Pablo Gutierrez
Division of Health Economics and Policy, National Institute of Public Health, Cuernavaca, Mexico
Lancet 364:63-4. 2004..We estimate that between US5.1 billion dollars and US5.9 billion dollars will be needed by the end of 2005 to provide ART, support programmes, and cover country-level administrative and logistic costs for 3 by 5...
- Polymorphism of human papillomavirus type 31 isolates infecting the genital tract of HIV-seropositive and HIV-seronegative women at risk for HIV infectionSimon Gagnon
, , , , Canada
J Med Virol 75:213-21. 2005..03). Four (23.5%) of 17 women with persistent versus 6 (25.0%) of 24 women with transient infections were infected by the prototype (P=1.00). HPV-31 LCR was more polymorphic than oncogenes and was associated with ethnicity...
- High levels of HPV-16 DNA are associated with high-grade cervical lesions in women at risk or infected with HIVJulie Fontaine
, , , , Canada
AIDS 19:785-94. 2005..007). CONCLUSION: Higher HPV-16 DNA loads are associated with cervical lesions detected by either histology or cytology. No additional information is gained by measuring integrated or episomal over total HPV-16 DNA loads...
- The global impact of scaling up HIV/AIDS prevention programs in low- and middle-income countriesJohn Stover
Futures Group/Constella, Glastonbury, CT 06033, USA
Science 311:1474-6. 2006..Thus, greater spending on prevention now would not only prevent more than half the new infections that would occur from 2005 to 2015 but would actually produce a net financial saving as future costs for treatment and care are averted...
- Complex emergencies, HIV, and substance use: no "big easy" solutionSteffanie A Strathdee
Department of Family and Preventive Medicine, University of California, San Diego, USA
Subst Use Misuse 41:1637-51. 2006
- Continuing HIV transmission among injection drug users in Eastern Central Canada: the SurvUDI Study, 1995 to 2000Catherine Hankins
Direction de la Santé Publique de Montréal Centre, Montreal, Canada
J Acquir Immune Defic Syndr 30:514-21. 2002..To document HIV prevalence/incidence trends from 1995-2000 and associated risk factors among injection drug users (IDUs) in Eastern Central Canada as an indication of harm reduction strategy effectiveness...